Patent US4006224A successfully refreshed from Google Patents.
US4006224A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and agent for treating inflammatory disorders of the gastrointestinal tract
Assignee: Lescarden Ltd
•
Filing: 1975-09-29
•
Granted: 1977-02-01
•
Expires: 1995-09-29
Abstract
Abstract A method for alleviating inflammatory diseases of the gastro intestinal tract by administration of a composition containing a D-glucosamine salt of a pharmaceutically acceptable acid. The invention also pertains to a new mode of administering D-glucosamine for treatment of inflammatory disorders of the gastrointestinal tract.
Inventors
- 👤 John Fletcher Prudden
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 04:26
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7004
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
31 words
A method of treating ulcerative colitis in a mammal afflicted with said condition which comprises administering to said mammal an effective amount for treating ulcerative colitis of a composition containing d-glucosamine.
Claim 2
Independent Claim
31 words
A method of treating ulcerative colitis in a mammal afflicted with said condition which comprises administering to said mammal an effective amount for treating ulcerative colitis of a composition containing d-glucosamine.
Claim 3
Dependent Claim
15 words
A method according to claim 1 which comprises orally administering said composition to said mammal.
Claim 4
Dependent Claim
15 words
A method according to claim 1 which comprises parenterally administering said composition to said mammal.
Claim 5
Dependent Claim
18 words
A method according to claim 2 which comprises administering D-glucosamine as the salt of a pharmaceutically acceptable acid.
Claim 6
Dependent Claim
17 words
A method according to claim 4 wherein said pharmaceutically acceptable acid salt of D-glucosamine comprises D-glucosamine hydrochloride.
Claim 7
Dependent Claim
29 words
A method according to claim 4 wherein said effective amount comprises from about 20 milligrams to about 300 milligrams of D-glucosamine hydrochloride per kilogram of body weight per day.
Claim 8
Dependent Claim
30 words
A method as recited in claim 6 wherein said effective amount comprises from about 50 milligrams to about 150 milligrams per kilogram of body weight per day of D-glucosamine hydrochloride.
Claim 9
Independent Claim
31 words
A method of treating regional enteritis in a mammal afflicted with said condition which comprises administering to said mammal an effective amount for treating regional enteritis of a composition containing d-glucosamine.
Claim 10
Independent Claim
31 words
A method of treating regional enteritis in a mammal afflicted with said condition which comprises administering to said mammal an effective amount for treating regional enteritis of a composition containing d-glucosamine.
Claim 11
Dependent Claim
15 words
A method according to claim 8 which comprises parenterally administering said composition to said mammal.
Claim 12
Dependent Claim
15 words
A method according to claim 8 which comprises orally administering said composition to said mammal.
Claim 13
Dependent Claim
18 words
A method according to claim 10 which comprises administering d-glucosamine as the salt of a pharmaceutically acceptable acid.
Claim 14
Dependent Claim
17 words
A method according to claim 11 wherein said pharmaceuticaly acceptable acid salt of d-glucosamine comprises d-glucosamine hydrochloride.
Claim 15
Dependent Claim
28 words
A method according to claim 12 wherein said effective amount comprises about 20 milligrams to about 300 milligrams of d-glucosamine hydrochloride per kilogram of body weight per day.
Claim 16
Dependent Claim
30 words
A method as recited in claim 13 wherein said effective amount comprises from about 50 milligrams to about 150 milligrams of d-glucosamine hydrochloride per kilogram of body weight per day.
Claim 17
Dependent Claim
27 words
A method according to claim 12 wherein said effective amount is administered in a solid form selected from the group consisting of a tablet and a capsule.
Claim 18
Dependent Claim
18 words
A method as recited in claim 12 wherein said effective amount is administered in a liquid dosage form.
Claim 19
Dependent Claim
23 words
A method as recited in claim 6 wherein said effective amount is administered in solid form selected from a tablet and a capsule.
Claim 20
Dependent Claim
18 words
A method as recited in claim 6 wherein said effective amount is administered in a liquid dosage form.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-02-01 | 1980-08-02 | 1981-02-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-02-01 | 1984-08-02 | 1985-02-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-02-01 | 1988-08-02 | 1989-02-01 | $7700.00 | Window Closed / Lapsed |